BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18282253)

  • 1. Pharmacokinetics of hydromorphone hydrochloride in healthy dogs.
    KuKanich B; Hogan BK; Krugner-Higby LA; Smith LJ
    Vet Anaesth Analg; 2008 May; 35(3):256-64. PubMed ID: 18282253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs.
    Smith LJ; KuKanich B; Hogan BK; Brown C; Heath TD; Krugner-Higby LA
    J Vet Pharmacol Ther; 2008 Oct; 31(5):415-22. PubMed ID: 19000260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration of a single dose to American kestrels (Falco sparverius).
    Guzman DS; KuKanich B; Drazenovich TL; Olsen GH; Paul-Murphy JR
    Am J Vet Res; 2014 Jun; 75(6):527-31. PubMed ID: 24866507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ammonium sulfate gradient loaded liposome-encapsulated oxymorphone and hydromorphone in healthy dogs.
    Smith LJ; Kukanich BK; Krugner-Higby LA; Schmidt BH; Heath TD
    Vet Anaesth Analg; 2013 Sep; 40(5):537-45. PubMed ID: 23601353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of hydrocodone and tramadol administered for control of postoperative pain in dogs following tibial plateau leveling osteotomy.
    Benitez ME; Roush JK; KuKanich B; McMurphy R
    Am J Vet Res; 2015 Sep; 76(9):763-70. PubMed ID: 26309104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food.
    Sathyan G; Xu E; Thipphawong J; Gupta SK
    BMC Clin Pharmacol; 2007 Feb; 7():2. PubMed ID: 17270055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of hydromorphone after intravenous and intramuscular administration in horses.
    Reed RA; Knych HK; Barletta M; Sakai DM; Ruch MM; Smyth CA; Ryan CA
    Vet Anaesth Analg; 2020 Mar; 47(2):210-218. PubMed ID: 31959534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of subcutaneously administered hydromorphone in bearded dragons (Pogona vitticeps) and red-eared slider turtles (Trachemys scripta elegans).
    Hawkins SJ; Cox S; Yaw TJ; Sladky K
    Vet Anaesth Analg; 2019 May; 46(3):352-359. PubMed ID: 30827804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of hydromorphone hydrochloride in healthy horses.
    Martins FC; Keating SC; Clark-Price SC; Schaeffer DJ; Lascola KM; DiMaio Knych H
    Vet Anaesth Analg; 2020 Jul; 47(4):509-517. PubMed ID: 32409257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental pharmacodynamics and analgesic efficacy of liposome-encapsulated hydromorphone in dogs.
    Krugner-Higby L; Smith L; Schmidt B; Wunsch L; Smetana A; Brown C; Heath TD
    J Am Anim Hosp Assoc; 2011; 47(3):185-95. PubMed ID: 21498589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of hydromorphone hydrochloride after intramuscular and intravenous administration of a single dose to orange-winged Amazon parrots (
    Sanchez-Migallon Guzman D; Knych H; Douglas J; Paul-Murphy JR
    Am J Vet Res; 2020 Nov; 81(11):894-898. PubMed ID: 33107746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration in guinea pigs (
    Ambros B; Knych HK; Sadar MJ
    Am J Vet Res; 2020 Apr; 81(4):361-366. PubMed ID: 32228262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of hydrorphone hydrochloride after intravenous and subcutaneous administration in ferrets (Mustela putorius furo).
    Hech B; Knych H; Desprez I; Weiner D; Ambros B
    Vet Anaesth Analg; 2024; 51(2):152-159. PubMed ID: 38158281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with renal impairment.
    Durnin C; Hind ID; Wickens MM; Yates DB; Molz KH
    Proc West Pharmacol Soc; 2001; 44():81-2. PubMed ID: 11794004
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacology of methadone in dogs.
    Ingvast-Larsson C; Holgersson A; Bondesson U; Lagerstedt AS; Olsson K
    Vet Anaesth Analg; 2010 Jan; 37(1):48-56. PubMed ID: 20017819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in young and elderly subjects.
    Durnin C; Hind ID; Ghani SP; Yates DB; Cross M
    Proc West Pharmacol Soc; 2001; 44():79-80. PubMed ID: 11794003
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with moderate hepatic impairment.
    Durnin C; Hind ID; Ghani SP; Yates DB; Molz KH
    Proc West Pharmacol Soc; 2001; 44():83-4. PubMed ID: 11794005
    [No Abstract]   [Full Text] [Related]  

  • 19. High bioavailability, short half-life, and metabolism into hydromorphone-3-glucuronide following single intramuscular and intravenous administration of hydromorphone hydrochloride to great horned owls (Bubo virginianus).
    Sosa-Higareda M; Sanchez-Migallon Guzman D; Knych HK; Hawkins MG
    Am J Vet Res; 2023 May; 84(5):. PubMed ID: 36881501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients.
    Davison SN; Mayo PR
    J Opioid Manag; 2008; 4(6):335-6, 339-44. PubMed ID: 19192761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.